UK distributor takes on controversial glucose device
This article was originally published in Clinica
Executive Summary
Biocontrol Technologies, the company which has been waging a 12-year unsuccessful battle to develop and gain FDA approval for its non-invasive glucose monitoring device, has signed a contract for the product with a UK distributor.